hsa-miR-936

ncRNA information

ncRNA name

hsa-miR-936

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

GPR78

Cancer information

Cancer name

Laryngeal Squamous Cell Carcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin/Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78

Tissue resource

laryngeal squamous cell carcinoma and matching normal tissues

human laryngeal squamous cell carcinoma cell lines Hep-2

normal bronchial epithelium cell lines 16HBE

human embryonic kidney cell lines 293T

human laryngeal squamous cell carcinoma cell line KB-3-1

Experiment

None


Institute

the Third Affiliated Hospital, Sun Yat-sen University and the Department of Head and Neck, Cancer Center, Sun Yat-sen University

China Center for Type Culture Collection

St. John's University

Country

China

China

United States

Continent

Asia

Asia

North Amercian